Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific lipid membranes and hydrophobic protein pockets refer to the physical environments within a biological system where lipophilic or amphipathic molecules preferentially accumulate. Lipid membranes, composed primarily of phospholipids, serve as the primary structural barrier of cells and organelles, while hydrophobic pockets are internal regions of proteins shielded from the aqueous environment (Young et al., 2011). Historically, these sites were considered the primary targets for general anesthetics under the Meyer-Overton hypothesis, which suggested that anesthetic potency correlated with lipid solubility (Franks & Lieb, 1994). While modern pharmacology identifies specific protein receptors for many drugs, non-specific interactions with these hydrophobic domains remain critical for drug pharmacokinetics and the action of membrane-disrupting antibiotics (Lohner, 2001). Interaction with these sites can lead to changes in membrane fluidity, altered protein stability, or direct lysis of the cell membrane. Consequently, these sites are often associated with systemic toxicity and off-target effects rather than specific therapeutic modulation. Drugs like polymyxins and daptomycin specifically exploit membrane interactions to exert antimicrobial effects, though they often face challenges regarding host cell toxicity (StatPearls, 2023). The hydrophobic effect drives the partitioning of non-polar molecules into these regions, minimizing their contact with water and potentially disrupting the structural organization of the cell (Young et al., 2011). Understanding these non-specific interactions is vital for biotech analysts when evaluating the safety profile and distribution characteristics of highly lipophilic drug candidates.
Non-specific disruption of membrane integrity, fluidization of the lipid bilayer, or partitioning into hydrophobic regions of proteins to alter their conformation or function (Franks & Lieb, 1994; Lohner, 2001).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific lipid membranes and hydrophobic protein pockets.